CLARKE JOHN K

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
CLARKE JOHN K's trades of aTyr Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
467.40
Quantity 63,532 +7.7%
Value US$934,804
Transaction date
Sale
Price
488.13
Quantity 32,984 +45.2%
Value US$744,616
Transaction date
Sale
Price
137.72
Quantity 22,153 -0.9%
Value US$321,593
Transaction date
Sale
Price
4.09
Quantity 5,440 -4.4%
Value US$22,250
Transaction date
Sale
Price
4.30
Quantity 2,200 -1.8%
Value US$9,451
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-25 2021-05-21
S Sale
63,532 +7.7%
467.40
US$934,804 		63,532 +7.7% 467.40 US$934,804
2020-09-03 2020-09-02
S Sale
32,984 +45.2%
488.13
US$744,616 		32,984 +45.2% 488.13 US$744,616
2020-09-03 2020-08-28
S Sale
22,153 -0.9%
137.72
US$321,593 		22,153 -0.9% 137.72 US$321,593
2020-08-28 2020-08-27
S Sale
5,440 -4.4%
4.09
US$22,250 		5,440 -4.4% 4.09 US$22,250
2020-08-28 2020-08-26
S Sale
2,200 -1.8%
4.30
US$9,451 		2,200 -1.8% 4.30 US$9,451
2004-07-01 2004-06-25
B Purchase
69,000 +3.3%
6.50
US$448,500 		69,000 +3.3% 6.50 US$448,500